- Filed
- Feb 24, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Feb 19, 2026 | 61.46M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 62.4M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 63.6M sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2023 | 63.7M sh |
| Stock Repurchased | FY 2025 · Dec 31, 2025 | $149.8M |
| Stock Repurchased | FY 2025 · Dec 31, 2024 | $162.8M |
| Stock Repurchased | FY 2025 · Dec 31, 2023 | $0 |
| Capex | FY 2025 · Dec 31, 2025 | $440M |
| Capex | FY 2025 · Dec 31, 2024 | $454.4M |
| Capex restated | FY 2025 · Dec 31, 2023 | $612.9M |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | $1.06B |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | $1.13B |
| Operating Cash Flow restated | FY 2025 · Dec 31, 2023 | $1.33B |
| Long Term Debt | FY 2025 · Dec 31, 2025 | $1.74B |
| Long Term Debt | FY 2025 · Dec 31, 2024 | $1.68B |
| Short Term Debt | FY 2025 · Dec 31, 2025 | $289.3M |
| Short Term Debt | FY 2025 · Dec 31, 2024 | $559.4M |
| Short Term Investments | FY 2025 · Dec 31, 2025 | $0 |
| Short Term Investments | FY 2025 · Dec 31, 2024 | $0 |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $856.1M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $666.6M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $8.37B |
| Stockholders Equity restated | FY 2025 · Dec 31, 2024 | $7.51B |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $2.72B |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $2.67B |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $5.31B |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $5.22B |
| Current Assets | FY 2025 · Dec 31, 2025 | $5.97B |
| Current Assets restated | FY 2025 · Dec 31, 2024 | $5.45B |
| Total Assets | FY 2025 · Dec 31, 2025 | $13.69B |
| Total Assets restated | FY 2025 · Dec 31, 2024 | $12.74B |
| Total Assets restated | FY 2025 · Dec 31, 2023 | $13.52B |
| Eps Diluted | FY 2025 · Dec 31, 2025 | $5.93 |
| Eps Diluted restated | FY 2025 · Dec 31, 2024 | $8.09 |
| Eps Diluted restated | FY 2025 · Dec 31, 2023 | −$7.05 |
| Eps Basic | FY 2025 · Dec 31, 2025 | $5.96 |
| Eps Basic restated | FY 2025 · Dec 31, 2024 | $8.13 |
| Eps Basic restated | FY 2025 · Dec 31, 2023 | −$7.05 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $2.07B |
| Sga Expense | FY 2025 · Dec 31, 2024 | $1.98B |
| Sga Expense restated | FY 2025 · Dec 31, 2023 | $2.12B |
| Net Income | FY 2025 · Dec 31, 2025 | $369.9M |
| Net Income restated | FY 2025 · Dec 31, 2024 | $514.7M |
| Net Income restated | FY 2025 · Dec 31, 2023 | −$449M |
| Operating Income | FY 2025 · Dec 31, 2025 | $489.8M |
| Operating Income restated | FY 2025 · Dec 31, 2024 | $693.5M |
| Operating Income restated | FY 2025 · Dec 31, 2023 | −$291.9M |
| Gross Profit | FY 2025 · Dec 31, 2025 | $2.57B |
| Gross Profit restated | FY 2025 · Dec 31, 2024 | $2.69B |
| Gross Profit restated | FY 2025 · Dec 31, 2023 | $2.71B |
| Cost Of Revenue | FY 2025 · Dec 31, 2025 | $8.21B |
| Cost Of Revenue restated | FY 2025 · Dec 31, 2024 | $8.15B |
| Cost Of Revenue restated | FY 2025 · Dec 31, 2023 | $8.43B |
| Revenue | FY 2025 · Dec 31, 2025 | $10.79B |
| Revenue | FY 2025 · Dec 31, 2024 | $10.84B |
| Revenue restated | FY 2025 · Dec 31, 2023 | $11.14B |